Shenzhen YHLO Biotech CoSHSE:688575 -3.03%64 Gross Margin % is 62.29% as of Mar. 2026, which is 10% above its 10-year median of 56.81. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.51 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks better than 71.8% on this metric.
SHSE:688575's Gross Margin % is ranked better than 71.8% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs SHSE:688575: 65.53
Shenzhen YHLO Biotech Co had a gross margin of 62.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Shenzhen YHLO Biotech Co (SHSE:688575) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shenzhen YHLO Biotech Co had a gross margin of 62.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shenzhen YHLO Biotech Co Gross Margin % Related Terms
Shenzhen YHLO Biotech Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688575 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen YHLO Biotech Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shenzhen YHLO Biotech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shenzhen YHLO Biotech Co (SHSE:688575) has a Gross Margin % of 62.29% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shenzhen YHLO Biotech Co and its competitors. This is 10% above median its historical median of 56.81. Over the past decade, Shenzhen YHLO Biotech Co's Gross Margin % has ranged from 36.63 to 65.53. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #227 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 28.2%.
Is Shenzhen YHLO Biotech Co's Gross Margin % too high?
Shenzhen YHLO Biotech Co's current Gross Margin % of 62.29% is 10% above median its 10-year median of 56.81. Over the past 10 years, this metric has ranged from a low of 36.63 to a high of 65.53. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Shenzhen YHLO Biotech Co's value of 62.29% is 19.7% above this industry median. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #227 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #227 out of 805 companies for Gross Margin %. This puts Shenzhen YHLO Biotech Co in the upper half of its industry. The industry median Gross Margin % is 52.03. Shenzhen YHLO Biotech Co's value of 62.29% is 19.7% above this benchmark. Historically, Shenzhen YHLO Biotech Co's own Gross Margin % has ranged from 36.63 to 65.53 over the past decade. While the company's 10-year median is 56.81 vs. the industry median of 52.03, Shenzhen YHLO Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen YHLO Biotech Co's current Gross Margin % of 62.29% is 19.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shenzhen YHLO Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current Gross Margin % is 62.29%, which is 10% above median its own 10-year median of 56.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.51, compared to a current price of ¥8.97 — trading 38.2% below its estimated fair value. The current Gross Margin % is 62.29%, which is 10% above median its 10-year median of 56.81 and 19.7% above the Medical Devices & Instruments industry median of 52.03. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current Gross Margin % is 62.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued.
The current stock price of ¥8.97 is trading 38.2% below its estimated GF Value™ of ¥14.51.
GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688575:
Gross Margin %: 62.29% (10% above median its 10-year median of 56.81)
GF Value™: ¥14.51 vs. price of ¥8.97 (38.2% below fair value)
Industry Position: 19.7% above the Medical Devices & Instruments median (#227 of 805)
No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score
Get the complete analysis for SHSE:688575
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688575 has been successfully added to your 
